| Logan Harrison Robertson, | |
|
11110 Medical Campus Rd Ste 200, Hagerstown, MD 21742-6797 | |
| (301) 714-4400 | |
| Not Available |
| Full Name | Logan Harrison Robertson |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 3 Years |
| Location | 11110 Medical Campus Rd Ste 200, Hagerstown, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093343402 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Meritus Medical Center, Inc | Hagerstown, MD | Home health agency |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Practices Of Antietam, Llc | 2567353865 | 184 |
News Archive
Researchers in the UK and the United States have reported concerning findings showing that patients who had recovered from coronavirus disease 2019 (COVID-19) exhibited significant cognitive deficits.
MDI has released a major enhancement to Viewpoint Analytics, a powerful web-based healthcare data warehousing, management, and reporting solution. Among the biggest additions to Viewpoint's suite of capabilities, MDI has integrated McKesson's CareEnhance Disease Monitor solution, improved Viewpoint's innovative medical risk scoring, and enhanced overall reporting speed and performance through data cubing.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it has initiated a Phase 2 clinical proof of concept trial of TC-5619 in adults with attention deficit/hyperactivity disorder (ADHD). TC-5619 is a novel small molecule that is highly selective for the alpha7 neuronal nicotinic receptor, which Targacept refers to as NNR, and was discovered by Targacept scientists using Targacept's proprietary drug discovery platform known as Pentad (TM).
Women need daily doses of the antiviral medication Truvada to prevent HIV infection while men only need two doses per week due to the way the drug accumulates in different body tissues, according to a new study from pharmacy researchers the University of North Carolina at Chapel Hill.
More than three decades after the identification of the human immunodeficiency virus, scientists are still working to develop a preventative vaccine that could finally put an end to the epidemic for which there are nearly two million new infections each year.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Logan Harrison Robertson, 11110 Medical Campus Rd Ste 200, Hagerstown, MD 21742-6797 Ph: (301) 714-4400 | Logan Harrison Robertson, 11110 Medical Campus Rd Ste 200, Hagerstown, MD 21742-6797 Ph: (301) 714-4400 |
News Archive
Researchers in the UK and the United States have reported concerning findings showing that patients who had recovered from coronavirus disease 2019 (COVID-19) exhibited significant cognitive deficits.
MDI has released a major enhancement to Viewpoint Analytics, a powerful web-based healthcare data warehousing, management, and reporting solution. Among the biggest additions to Viewpoint's suite of capabilities, MDI has integrated McKesson's CareEnhance Disease Monitor solution, improved Viewpoint's innovative medical risk scoring, and enhanced overall reporting speed and performance through data cubing.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it has initiated a Phase 2 clinical proof of concept trial of TC-5619 in adults with attention deficit/hyperactivity disorder (ADHD). TC-5619 is a novel small molecule that is highly selective for the alpha7 neuronal nicotinic receptor, which Targacept refers to as NNR, and was discovered by Targacept scientists using Targacept's proprietary drug discovery platform known as Pentad (TM).
Women need daily doses of the antiviral medication Truvada to prevent HIV infection while men only need two doses per week due to the way the drug accumulates in different body tissues, according to a new study from pharmacy researchers the University of North Carolina at Chapel Hill.
More than three decades after the identification of the human immunodeficiency virus, scientists are still working to develop a preventative vaccine that could finally put an end to the epidemic for which there are nearly two million new infections each year.
› Verified 1 days ago
Wanda Lumpkins, DMSC, MPAS, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 18800 Roxbury Rd, Hagerstown, MD 21746 Phone: 240-420-1601 | |
Juris G. Eyler, PA-S Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 11110 Medical Campus Rd, Suite 205, Hagerstown, MD 21742 Phone: 301-665-4950 Fax: 301-665-4956 | |
Mrs. Julie Diane Cathor, P.A. - C Physician Assistant Medicare: Medicare Enrolled Practice Location: 11110 Medical Campus Rd, Suite 100, Hagerstown, MD 21742 Phone: 240-313-9640 | |
Dildeep Kaur Ghallon, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 24 N Walnut St Fl 3, Hagerstown, MD 21740 Phone: 240-527-2752 | |
Rebecca A Kreps, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1165 Imperial Drive, Suite 300, Hagerstown, MD 21740 Phone: 301-665-9098 Fax: 301-665-9096 | |
Kimberly Anne Olchewsky, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 11110 Medical Campus Rd Ste 147, Hagerstown, MD 21742 Phone: 301-714-4350 Fax: 301-714-4353 | |
Ms. Sarah N Faith, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 17 Western Maryland Pkwy Ste 100, Hagerstown, MD 21740 Phone: 301-797-9240 Fax: 301-797-4234 |